Literature DB >> 34251050

Enigmatic inflammasomes - Sequel (Part 2).

Kathy Triantafilou1,2.   

Abstract

In this issue, we introduce the second part of our review series focusing on lesser-known enigmatic inflammasomes. This part of the collection introduces one more under-studied NLR, NLRP7, and not only its role as a regulator of inflammation in response to bacterial infections but also its non-inflammasome role in early pregnancy. In addition, the enigmatic function of extracellular ASC specks is also introduced, where extracellular ASC specks are presented as 'danger signals' to propagate inflammation. The series is concluded with an article that reviews the immunometabolic regulation of all of these lesser-known NLRs, demonstrating that metabolic regulation of inflammasome activation is central for the whole NLR family. These three reviews, together with the four articles that were published in the first part of the series in December 2020, offer new insights into the complex functions of NLRs, well beyond the well-known NLRP3. The review series as a whole provides a thought-provoking platform with some of the latest findings in the NLR field and sparks our imagination into what might be discovered in this space in the future.
© 2021 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34251050      PMCID: PMC8274183          DOI: 10.1111/imm.13387

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.215


  9 in total

1.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death.

Authors:  Jianjin Shi; Yue Zhao; Kun Wang; Xuyan Shi; Yue Wang; Huanwei Huang; Yinghua Zhuang; Tao Cai; Fengchao Wang; Feng Shao
Journal:  Nature       Date:  2015-09-16       Impact factor: 49.962

2.  Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling.

Authors:  Nobuhiko Kayagaki; Irma B Stowe; Bettina L Lee; Karen O'Rourke; Keith Anderson; Søren Warming; Trinna Cuellar; Benjamin Haley; Merone Roose-Girma; Qui T Phung; Peter S Liu; Jennie R Lill; Hong Li; Jiansheng Wu; Sarah Kummerfeld; Juan Zhang; Wyne P Lee; Scott J Snipas; Guy S Salvesen; Lucy X Morris; Linda Fitzgerald; Yafei Zhang; Edward M Bertram; Christopher C Goodnow; Vishva M Dixit
Journal:  Nature       Date:  2015-09-16       Impact factor: 49.962

3.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

Authors:  Fabio Martinon; Kimberly Burns; Jürg Tschopp
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

Review 4.  MHC class I transactivator NLRC5 in host immunity, cancer and beyond.

Authors:  Steven X Cho; Saptha Vijayan; Ji-Seung Yoo; Toshiyuki Watanabe; Ryota Ouda; Ning An; Koichi S Kobayashi
Journal:  Immunology       Date:  2020-08-03       Impact factor: 7.397

Review 5.  NLR in eXile: Emerging roles of NLRX1 in immunity and human disease.

Authors:  Robert J Pickering; Lee M Booty
Journal:  Immunology       Date:  2020-12-28       Impact factor: 7.397

Review 6.  NLRP9 in innate immunity and inflammation.

Authors:  Breanne Mullins; Jueqi Chen
Journal:  Immunology       Date:  2020-12-20       Impact factor: 7.397

Review 7.  Metabolic regulators of enigmatic inflammasomes in autoimmune diseases and crosstalk with innate immune receptors.

Authors:  Gisela Jimenez-Duran; Martha Triantafilou
Journal:  Immunology       Date:  2021-05-02       Impact factor: 7.397

Review 8.  NLRP7: From inflammasome regulation to human disease.

Authors:  Jessica Carriere; Andrea Dorfleutner; Christian Stehlik
Journal:  Immunology       Date:  2021-06-30       Impact factor: 7.215

Review 9.  The NLRP6 Inflammasome.

Authors:  Danping Zheng; Lara Kern; Eran Elinav
Journal:  Immunology       Date:  2020-12-12       Impact factor: 7.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.